↓ Skip to main content

Gliadel® wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial

Overview of attention for article published in Acta Neurochirurgica, February 2006
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

policy
1 policy source
patent
3 patents

Citations

dimensions_citation
373 Dimensions

Readers on

mendeley
196 Mendeley
Title
Gliadel® wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial
Published in
Acta Neurochirurgica, February 2006
DOI 10.1007/s00701-005-0707-z
Pubmed ID
Authors

M. Westphal, Z. Ram, V. Riddle, D. Hilt, E. Bortey, On behalf of the Executive Committee of the Gliadel® Study Group

Abstract

Adjuvant systemic chemotherapy increases survival of primary malignant glioma patients beyond 12-18 months. The only interstitial chemotherapy treatment approved for malignant glioma is Gliadel wafer containing carmustine (BCNU) placed in the resection cavity at surgery. Analysis of a large trial by Westphal and colleagues (n = 240) showed a 29% risk reduction (P = 0.03) in the BCNU wafer-treated group over the course of the 30-month trial. Long-term follow-up of these patients was undertaken to determine the survival benefit at 2 and 3 years.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 196 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Nepal 1 <1%
France 1 <1%
Australia 1 <1%
Brazil 1 <1%
Ukraine 1 <1%
Argentina 1 <1%
Unknown 190 97%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 43 22%
Researcher 33 17%
Student > Master 18 9%
Other 15 8%
Student > Doctoral Student 14 7%
Other 45 23%
Unknown 28 14%
Readers by discipline Count As %
Medicine and Dentistry 61 31%
Agricultural and Biological Sciences 23 12%
Neuroscience 16 8%
Biochemistry, Genetics and Molecular Biology 14 7%
Pharmacology, Toxicology and Pharmaceutical Science 13 7%
Other 38 19%
Unknown 31 16%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 10 November 2022.
All research outputs
#3,323,760
of 23,072,295 outputs
Outputs from Acta Neurochirurgica
#150
of 1,937 outputs
Outputs of similar age
#7,420
of 70,710 outputs
Outputs of similar age from Acta Neurochirurgica
#2
of 7 outputs
Altmetric has tracked 23,072,295 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,937 research outputs from this source. They receive a mean Attention Score of 4.2. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 70,710 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 7 others from the same source and published within six weeks on either side of this one. This one has scored higher than 5 of them.